Last reviewed: June 22, 2026
Last updated: June 22, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Wegovy, has demonstrated consistent weight loss outcomes in clinical trials, with participants losing an average of 15 pounds per month during the first weeks of treatment. Individual results depend on starting weight, metabolic genetics, and adherence to diet and exercise. PlexusDx compounded semaglutide injections deliver the same mechanism of action as brand-name options at significantly lower cost.
Clinical Trial Data: How Much Weight Do Patients Lose on Semaglutide?
The STEP clinical trial program tracked over 4,500 participants taking semaglutide for weight management. At the highest maintenance dose (2.4 mg weekly), participants lost an average of 22% of their starting body weight—roughly 35 pounds for someone weighing 250 pounds at baseline. Lower maintenance doses (1.7 mg) produced average losses of 16%, while the 0.5 mg dose achieved 9–11% weight reduction. These results were measured over 68 weeks of consistent treatment.
Weight loss typically follows a pattern: rapid initial loss during the first 8–12 weeks, then steady reduction during months 3–6, with plateau effects beginning around month 4. Most of the heavy lifting occurs in the first 16 weeks when appetite suppression is most pronounced. After reaching a plateau, many patients stabilize at their new weight with continued medication adherence.
Factors That Influence Your Personal Weight Loss Results
Genetics play a significant role in how effectively semaglutide works for each individual. Variations in the GLP-1 receptor gene (GLP1R rs6923761), the GIPR receptor gene (GIPR rs1800437), and metabolic genes like FTO rs9939609 influence medication response, appetite suppression intensity, and how quickly your body mobilizes stored fat. The Precision Peptide Genetic Test from PlexusDx identifies these pathways, helping providers tailor dose progression and medication selection to your unique biology.
Lifestyle factors compound genetic predisposition: consistent calorie reduction amplifies weight loss by 5–10%, while regular resistance training preserves muscle mass during rapid fat loss. Sleep quality, stress management, and baseline activity level also shift outcomes significantly. Patients who combine medication with structured nutrition see results 30–40% greater than those relying on medication alone.
Comparing Semaglutide to Other GLP-1 Weight Loss Medications
Semaglutide and tirzepatide represent different GLP-1 mechanisms: semaglutide targets the GLP-1 receptor alone, while tirzepatide activates both GLP-1 and GIP receptors (dual agonism). In direct comparison, tirzepatide users lost 20–22% body weight at maximum doses, slightly outperforming semaglutide's 15–22% range. However, individual responses vary; some patients achieve superior results with semaglutide due to genetic variants affecting receptor sensitivity.
Oral formulations (semaglutide tablets, tirzepatide capsules) deliver lower bioavailability than injections, typically producing 60–70% of the weight loss seen with injectables at equivalent dose levels. PlexusDx offers both delivery formats: compounded semaglutide injections starting at $149/month and oral alternatives at $249/month, allowing flexibility based on preference, absorption capacity, and genetic predictors of response.
What to Expect: Timeline and Realistic Weight Loss Progression
Week 1–4: Appetite suppression intensifies, with nausea common during titration; weight loss averages 2–4 pounds weekly due to reduced caloric intake and fluid shifts. Week 5–12: Metabolic adaptation deepens, with GLP-1 receptors throughout your brain and digestive tract becoming fully activated; weekly loss often slows to 1–3 pounds but fat loss (not water) dominates. Month 4–6: Plateau phases emerge as your body adjusts; dose increases (typically from 0.5 mg to 1.0 mg, then 1.7 mg, and finally 2.4 mg) renew appetite suppression and fat mobilization.
Long-term stability (6+ months): Patients who remain on maintenance doses sustain their weight loss indefinitely, with only mild regain (5–10%) reported after medication discontinuation in studies. Those who combine semaglutide with behavioral changes—like intermittent fasting, protein prioritization, or structured exercise—maintain weight loss even more successfully. PlexusDx patients with genetic testing insights adjust their approach based on peptide-pathway predispositions, optimizing adherence and durability.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is 22% weight loss realistic for everyone taking Wegovy or semaglutide?
No. The 22% average comes from the highest dose (2.4 mg) in clinical trials with strict adherence. Starting at lower doses, experiencing side effects, or having genetic variants that reduce GLP-1 receptor sensitivity may lower your outcome to 10–18%. PlexusDx's Precision Peptide Genetic Test maps 14 pathways to predict your likely response range before beginning treatment.
How long does it take to see weight loss on semaglutide?
Most patients notice appetite changes within 3–5 days of the first injection, with measurable weight loss (2–4 lbs) by week 2–3. Significant cumulative loss becomes apparent by week 6–8, when dose titration often increases. Full efficacy at maintenance doses emerges around week 12–16.
Can I get semaglutide for weight loss affordably without Wegovy's brand price?
Yes. PlexusDx compounded semaglutide injections start at $149/month, compared to Wegovy's typical $900–$1,300/month out-of-pocket cost. All medications come from licensed 503A compounding pharmacies, are HSA/FSA eligible, and serve all 50 states without membership fees or insurance requirements.
Will I regain weight if I stop taking semaglutide?
Clinical data shows approximately 50–70% of lost weight returns within 1 year after discontinuation, though some patients maintain improved eating behaviors and activity levels indefinitely. This is why long-term treatment is typically recommended for chronic weight management, similar to blood pressure or cholesterol medication.
Does genetic testing improve my weight loss results on semaglutide?
PlexusDx's Precision Peptide Genetic Test ($99 add-on after first month) identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence how effectively your body responds to semaglutide and whether tirzepatide or higher doses may work better. This intelligence helps providers personalize your treatment plan for optimal outcomes.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Mastering Your Path to Health: How Often Do You Increase Zepbound Dose for Effective Weight Management?
Understanding the Maximum Dosage of Mounjaro for Effective Weight Management